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Sir,
The paper by Yoshikawa et al (2008) is of considerable interest to
our group. The authors assessed the expression of Gli-1 in the
residual squamous cell carcinoma of the oesophagus in the resected
specimens of the patients treated with preoperative chemoradiation.
The expression of Gli-1 correlated with poor prognosis. When
employing the strategy of preoperative chemoradiation in oesopha-
geal carcinoma, the prognosis of the patients can be determined by
assessing the degree of residual cancer (Chirieac et al, 2005; Wu et al,
2007). In addition, the residual cancer correlates with metastatic
potential (Rohatgi et al,2 0 0 5 ) .I tw o u l db eo fi n t e r e s tt od o c u m e n t
that Gli-1 expression has an independent prognostic value. The
authors did not report a multivariate analysis. Our group first
documented the expression and temporal kinetics of sonic hedgehog
ligand and Gli-1 protein expression in a xenograft model using
oesophageal cancer cell lines (Sims-Mourtada et al, 2006). Both
biomarkers correlated with chemoradiation resistance and dynamics
of tumour repopulation after chemoradiation (Sims-Mourtada et al,
2006). Furthermore, our group documented that sonic hedgehog
signalling mediates chemotherapy resistance through multiple drug
transporter mechanisms and that this resistance can be overcome by
inhibitors of the sonic hedgehog pathway (Sims-Mourtada et al,
2007). Unfortunately, Yoshikawa et al (2008) have neglected to
discuss these two publications.
REFERENCES
Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth
JA, Rashid A, Hamilton SR, Wu TT (2005) Posttherapy pathologic stage
predicts survival in patients with esophageal carcinoma receiving
preoperative chemoradiation. Cancer 103: 1347–1355
Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G,
Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA (2005) Failure patterns
correlate with the proportion of residual carcinoma after preoperative
chemoradiotherapy for carcinoma of the esophagus. Cancer 104: 1349–1355
Sims-Mourtada J, Izzo JG, Ajani J, Chao KS (2007) Sonic Hedgehog
promotes multiple drug resistance by regulation of drug transport.
Oncogene 26: 5674–5679
Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra
R, Liao Z, Komaki R, van der Kogel A, Ajani J, Chao KS (2006)
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy
and a target to improve radiation response. Clin Cancer Res 12:
6565–6572
Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A,
Correa AM, Hofstetter WL, Ajani JA, Swisher SG (2007) Excellent
interobserver agreement on grading the extent of residual carcinoma
after preoperative chemoradiation in esophageal and esophagogastric
junction carcinoma: a reliable predictor for patient outcome. Am J Surg
Pathol 31: 58–64
Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M,
Tsujimura T, Hashimoto-Tamaoki T, Fujiwara Y (2008) Hedgehog signal
activation in oesophageal cancer patients undergoing neoadjuvant
chemoradiotherapy. 98: 1670–1674
Published online 2 September 2008
*Correspondence: Professor JA Ajani;
E-mails: jajani@mdanderson.org or jafferajani@mac.com
British Journal of Cancer (2008) 99, 1195
& 2008 Cancer Research UK All rights reserved 0007– 0920/08 $32.00
www.bjcancer.com